In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amicus Therapeutics Inc.

www.amicusrx.com

Latest From Amicus Therapeutics Inc.

Pharma Intelligence Congratulates The CARE Awards Winners

The fourth annual CARE Awards returned to Boston, Massachusetts, 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.
Clinical Trials Innovation

Pharma Intelligence Congratulates The CARE Awards Winners

The fourth annual CARE Awards returned to Boston, Massachusetts, 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.
Clinical Trials Innovation

UK NICE Processes Not Fit For Orphan Drugs, Says New Report

UK health technology appraisal body NICE says it will carefully review a new report that has found its processes block access to orphan drugs.

Health Technology Assessment Rare Diseases

Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

Already having launched several portfolio companies, Roivant goes a step further by spinning out CNS specialist Arvelle from Axovant. BI and IBM will incorporate blockchain technology in clinical trials, while AbbVie licenses multiple myeloma candidate from TeneoBio.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amicus Therapeutics Inc.
  • Senior Management
  • John F Crowley, Chmn. & CEO
    Chip D Baird, CFO
    Jay A Barth, MD, CMO
    Bradley L Campbell, Pres. & COO
    Jeffrey P Castelli, PhD, Chief Portfolio Officer
  • Contact Info
  • Amicus Therapeutics Inc.
    Phone: (609) 662-2000
    1 Cedar Brook Dr.
    Cranbury, NJ 08512
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register